Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
33,289,095
-
Number of holders
-
55
-
Total 13F shares, excl. options
-
4,022,892
-
Shares change
-
-274,176
-
Total reported value, excl. options
-
$66,543,749
-
Value change
-
-$4,425,895
-
Put/Call ratio
-
2.28%
-
Number of buys
-
20
-
Number of sells
-
-33
-
Price
-
$16.56
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q2 2021
67 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q2 2021.
XBiotech Inc. - Common Shares, no par value (XBIT) has 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,022,892 shares
of 33,289,095 outstanding shares and own 12.08% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,201,597 shares), VANGUARD GROUP INC (851,416 shares), STATE STREET CORP (408,754 shares), GEODE CAPITAL MANAGEMENT, LLC (297,922 shares), NORTHERN TRUST CORP (221,960 shares), WELLS FARGO & COMPANY/MN (210,484 shares), CREDIT SUISSE AG/ (157,215 shares), Bank of New York Mellon Corp (54,119 shares), Swiss National Bank (41,900 shares), and ALPS ADVISORS INC (39,486 shares).
This table shows the top 55 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.